Scholars Central

Conference abstractPublished 18 Jul 2022

Synthesis of widely-soluble biocompatible ionic liquids aiming to enhance transdermal drug delivery system

Authors: Shihab Uddin

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Ionic Liquids (ILs) are a novel class of environmentally benign and tailor-made solvents. They have been increasingly exploited as solvents, co-solvents, and/or materials in the fields of pharmaceutical drug delivery and Active Pharmaceutical Ingredient (API) formulation because of their unique properties. ILs ensures potent therapeutic action by solubilizing or stabilizing as well as enhancing skin penetration of drugs in Transdermal Drug Delivery Systems (TDDSs). We’ve developed three novel Lipid-Based Bio-Ils (LBILs), each including a long chain phosphonium cation, the phosphatidylcholine derivative named 1,2-dimyristoyl-sn-glycero-3- ethyl-phosphatidylcholine; EDMPC (similar to natural lipids on the skin) and a long-chain Fatty Acid (FA). In the synthesis of LBILs, EDMPC Chloride (EDMPC-Cl) was first synthesized by a series of reactions under specific conditions. Then, the combination of equimolar amounts of either linoleic, oleic, or stearic acid with the EDMPC-Cl synthesize three LBILs, [EDMPC][Lin], [EDMPC][Ole], and [EDMPC][Ste]. At room temperature, [EDMPC][Lin], [EDMPC][Ole] and [EDMPC][Ste] are viscous liquid, highly viscous liquid and semi-solid respectively. The purity, thermal phase behavior, and identical properties of LBILs were optimized by proton Nuclear Magnetic Resonance (1H NMR), Fourier Transform Infrared (FTIR) spectroscopy, Differential Scanning Calorimetry (DSC), Elemental Analysis (EA), Mass Spectroscopy (MS), Dynamic Light Scattering (DLS) and UV visible spectroscopy. The three LBILs were found soluble at an equal ratio in both polar (ethanol, methanol, etc.) and non-polar solvents (hexane, heptane, etc.) solvents. DLS and UV analysis revealed that LBILs were molecularly soluble in nonpolar solvents and dispersible in polar solvents by forming microemulsions/ nanoparticles. Using an artificial three-dimensional human epidermis model these compounds were tested for biocompatibility in a well-established skin irritation test (MTT-assay) only to exhibit excellent biocompatibility. The Ionic-Liquid-in-Oil-Nanodispersions (IL/O-NDs) from three LBILs enhanced the transdermal permeation of the peptide to the skin layers by deforming its lipid and protein arrangements to enhance the transdermal permeation of the peptide compared to other Conventional Skin Permeation Enhancers (CPE) and Tween-80. Transdermal peptide delivery profiles of IL/O-NDs of these three peptide-LBIL complexes revealed that [EDMPC][Lin]/O-ND was the most preferable for a TDDS based on the pharmacokinetic parameters compared to others. These results clearly state the assurance of enhanced TDDS by synthesis of these universal soluble biocompatible Ionic Liquids (Figure 1).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalGeneral Medicine: Open Access
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Shihab Uddin”